Compositions Comprising Nicotinic Agonists and Methods of Using Same
AssigneeNeuroDerm, Ltd.
InventorEliahu Heldman
Life of this patent
Estimating the term…
Abstract
The disclosure is directed at least in part to compositions and methods comprising nicotinic agonists for treating e.g., nervous system disorders, in particular, to combination therapies that include a nicotinic agonist (for example, nicotine) and a nicotinic acetylcholine receptor desensitization inhibitor (for example, opipramol).
Claims29
A method for treatment of a central nervous system (CNS) or a peripheral nervous system disorder, comprising co-administering to a patient in need thereof a therapeutically effective amount of a nicotinic agonist and a nicotinic acetylcholine receptor (nAChR) desensitization inhibitor.
4-7. (canceled)
(canceled)
11-12. (canceled)
15-17. (canceled)
(canceled)
21-25. (canceled)
27-29. (canceled)
(canceled)
36-61. (canceled)
A controlled release medical device for delivery of a composition comprising a) nicotine, b) opipramol or a pharmaceutically acceptable salt, ester, or a prodrug thereof;
- which is capable of delivering the composition in a pre-determined delivery rate to a patient.
63-66. (canceled)
Dependencies are inferred from the claim text.